What are the typical symptoms and clinical findings of gestational trophoblastic disease?

Gestational Trophoblastic Disease Symptoms

The most common presentation of gestational trophoblastic disease is irregular vaginal bleeding in early pregnancy (occurring in approximately 60% of cases), accompanied by a positive pregnancy test and supporting ultrasound findings. 1

Primary Clinical Presentation

Most Common Symptoms

Vaginal bleeding remains the dominant presenting symptom, typically occurring around 6-16 weeks of gestation 2. However, due to widespread first-trimester ultrasound screening, many patients are now diagnosed while completely asymptomatic, with abnormal ultrasound findings as the sole presenting feature (increased from 1% to 12% between 1996-2006) 1.

The mean gestational age at diagnosis has decreased dramatically—from 16 weeks (1965-1975) to approximately 9-10 weeks currently (1994-2013), meaning the classic "textbook" presentations are now uncommon 1.

Less Common but Important Presentations

The following symptoms occur less frequently but should raise clinical suspicion 1, 3:

• Hyperemesis gravidarum (severe nausea/vomiting beyond typical morning sickness)
• Excessive uterine enlargement (uterus larger than expected for gestational age)
• Hyperthyroidism symptoms (due to hCG cross-reactivity with TSH receptors)
• Early-onset pre-eclampsia (before 20 weeks gestation—highly unusual in normal pregnancy)
• Abdominal distension from theca lutein ovarian cysts

Rare but Critical Presentations (Metastatic Disease)

Very rarely, patients present with symptoms of metastatic gestational trophoblastic neoplasia 1:

• Hemoptysis (coughing blood from lung metastases)
• Seizures or neurological symptoms (from brain metastases)
• Pulmonary symptoms (shortness of breath, chest pain)

Clinical Findings on Examination

Physical Examination Findings

• Enlarged, irregular uterus (may be larger or smaller than expected for dates)
• Bilateral ovarian enlargement (theca lutein cysts, palpable in some cases)
• Vaginal bleeding (active or on speculum examination)

Laboratory Findings

• Markedly elevated hCG levels: Complete molar pregnancies often have hCG >100,000 IU/L, though this occurs in fewer than 10% of partial moles 2
• Anemia (from chronic bleeding)
• Thyroid function abnormalities (if hyperthyroidism present)

Ultrasound Characteristics

Complete Molar Pregnancy

The classic "snowstorm appearance" (heterogeneous mass with multiple small cystic spaces) is typically seen only in second-trimester presentations—now uncommon 2, 4.

In first-trimester diagnosis (now the norm), ultrasound shows 1:

• Polypoid mass between 5-7 weeks
• Thickened cystic appearance of villous tissue after 8 weeks
• No identifiable gestational sac or fetal tissue
• Vesicular pattern from hydropic chorionic villi

Important caveat: Most histologically proven molar pregnancies are initially diagnosed on ultrasound as "delayed miscarriage" or "anembryonic pregnancy" 1. Pre-removal diagnosis accuracy is only 35-40% before 14 weeks, increasing to 60% after 14 weeks 1.

Partial Molar Pregnancy

Ultrasound findings are more subtle and easily missed 1:

• Focal cystic spaces within the placenta
• Enlarged placenta with cystic changes
• Gestational sac that is empty or elongated (transverse:anteroposterior ratio >1.5:1)
• May show fetal tissue, fetal anomalies, or fetal demise

The positive predictive value is low: only 40% for complete moles and 22% for partial moles 1.

Key Clinical Pitfalls to Avoid

1. Don't rely solely on ultrasound: Sensitivity for partial mole is only 20%, and many complete moles appear as missed miscarriage 1. Histological examination of all pregnancy tissue after evacuation is mandatory 1.

2. Don't dismiss early pregnancy bleeding: When pregnancy tissue is routinely examined after surgical removal, 2.7% of cases initially unrecognized as GTD are identified 1.

3. Don't expect "classic" symptoms: The historical presentation of marked uterine enlargement, severe hyperemesis, early pre-eclampsia, and hyperthyroidism is now rare due to early ultrasound detection 2, 4.

4. Don't biopsy visible vaginal lesions: In cases of suspected metastatic disease with visible lower genital tract lesions, biopsy is contraindicated due to severe hemorrhage risk 2.

Diagnostic Algorithm

When GTD is suspected based on symptoms:

1. Quantitative serum hCG (markedly elevated suggests complete mole)
2. Pelvic ultrasound (preferably with Doppler)
3. Chest X-ray (baseline and if metastases suspected)
4. Complete blood count (assess anemia)
5. Thyroid function tests (if hyperemesis or hyperthyroidism symptoms)
6. Blood type and screen (prepare for potential hemorrhage)
7. Suction curettage under ultrasound guidance with mandatory histological examination 2

The diagnosis is confirmed by histopathology, not imaging alone. Registration with a specialized GTD center represents the minimum standard of care, as outcomes are significantly better with expert management (cure rates 98-100%) 1.